Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function
Sponsor
Rabin Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00418119
Collaborator
(none)
10
1
12
0.8
Study Details
Study Description
Brief Summary
Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Phase 4 Study on the Efficacy of Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function
Study Start Date
:
Jan 1, 2007
Study Completion Date
:
Jan 1, 2008
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Ischemic heart disease
-
Systolic lv dysfunction
-
Mild anemia
-
Normal renal function
-
Stable condition
Exclusion Criteria:
-
Pregnancy
-
Unstable condition
-
Under 18 years old
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Cardiology Department, Rabin Medical Center | Petah Tikva | Israel | 49100 |
Sponsors and Collaborators
- Rabin Medical Center
Investigators
- Principal Investigator: Tuvia Ben Gal, MD, Cardiology Department Rabin medical Center
- Study Director: Ofer Shpilberg, Prof., Hematology Department Rabin Medical Center
- Study Director: Daniel Murninkas, MD, Cardiology Department Rabin Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00418119
Other Study ID Numbers:
- 4273
First Posted:
Jan 4, 2007
Last Update Posted:
Jan 4, 2007
Last Verified:
Dec 1, 2006